China: Retail price management case highlights clashing approaches to antitrust law
A ruling by the Shanghai Intermediate People’s Court against Rainbow Medical, which alleged Johnson & Johnson hampered competition with a contract between the two parties, has been appealed to the Shanghai Higher People’s Court. According to a report, the situation is part of a larger trend of conflicting governmental approaches to retail price maintenance cases under the PRC Anti-monopoly Law. Quoted is antitrust lawyer Zhaofeng Zhou, noting that in this particular case the court used an approach “similar to the US rule of reason,” while the National Development and Reform Commission, China’s antitrust authority, used the per se illegal approach “commonly found in the EU.”
Featured News
Croatia Competition Authority Approves HPB Acquisition of Croatia Banka
Jul 19, 2026 by
CPI
Democratic Lawmakers Urge DOJ to Closely Examine Fox-Roku Merger
Jul 19, 2026 by
CPI
US Judge Clears Path for Broad Beef Antitrust Class Actions Against Major Meatpackers
Jul 19, 2026 by
CPI
India’s Competition Regulator Dismisses Antitrust Complaint Against Reliance Jio and 4,500 Firms
Jul 19, 2026 by
CPI
Apple Opens Early Settlement Discussions With DOJ
Jul 17, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Agentic AI & Antitrust
Jul 16, 2026 by
CPI
AI Agents and Collusion: The Two Faces of Agentic AI
Jul 16, 2026 by
Giovanna Massarotto
Agentic AI’s Regulatory Conundrum
Jul 16, 2026 by
Anant Raut
Inter-AI-Agent Competition
Jul 16, 2026 by
Stefan Thomas
Navigating the Increasing Regulatory Scrutiny of AI-Pricing Tools: Competition and Other Emerging Risks
Jul 16, 2026 by
Mark Krotoski & Vinny Sidhu